Brookfield and CPP Investments to Buy LXP Industrial for $5.2 Billion
Brookfield and CPP Investments have agreed to a $5.2 billion deal to take LXP Industrial Trust private in an all-cash transaction.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Brookfield and CPP Investments have reached an agreement to acquire LXP Industrial Trust for $5.2 billion. According to reports from the Wall Street Journal, Reuters, and Bloomberg, the deal is structured to take the company, which is listed on the New York Stock Exchange under the ticker LXP, private. Seeking Alpha further clarifies that this acquisition will be executed as a cash transaction. The agreement marks a significant shift in ownership for the trust as it moves from the public market to the private control of the two investment entities. Major financial and industry outlets are tracking the development, with Connect CRE and The Real Deal highlighting the strategic nature of the $5.2 billion buyout.
Coverage also specifies the professional services involved in the transaction, with O'Dwyer's PR reporting that Joele Frank is working on the deal. The scale of the acquisition has drawn widespread attention across business media, emphasizing the coordinated effort between Brookfield and CPP Investments to secure the assets of LXP Industrial Trust. Parallel to the announcement of the acquisition, legal scrutiny has emerged regarding the valuation of the deal. According to PR Newswire, the M&A Class Action Firm has announced an investigation into LXP Industrial Trust. Similarly, Ademi LLP has issued a shareholder alert to investigate whether public shareholders are obtaining a fair price for their holdings.
These legal actions indicate a tension between the agreed-upon purchase price and the perceived value for the public investors holding LXP stock on the NYSE. Future developments will likely center on the resolution of the investigations launched by Ademi LLP and the M&A Class Action Firm. Observers will be monitoring whether these investigations lead to formal legal challenges regarding the $5.2 billion price point. The completion of the transition to a private entity depends on the finalization of the agreement between Brookfield, CPP Investments, and the shareholders of LXP Industrial Trust, as well as any potential outcomes from the current shareholder alerts.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 113d ago.
Quick answers
Who is acquiring LXP Industrial Trust?
The acquisition is being carried out by Brookfield and CPP Investments.
What is the total value of the deal?
The deal is valued at $5.2 billion.
Why are there legal investigations following the announcement?
The M&A Class Action Firm and Ademi LLP are investigating whether public shareholders are receiving a fair price for the acquisition.
Coverage (9)
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of LXP Industrial Trust (NYSE: LXP) PR Newswire · 119d ago
- Brookfield, CPP strike $5.2B deal to take LXP Industrial Trust private The Real Deal · 119d ago
- Brookfield, CPP Taking LXP Industrial Private in $5.2B Deal Connect CRE · 119d ago
- LXP Industrial Trust agrees to $5.2 billion deal by Brookfield, CPP Investments Reuters · 119d ago
- Shareholder Alert: Ademi LLP investigates whether LXP Industrial Trust is obtaining a Fair Price for Public Shareholders PR Newswire · 119d ago
- PR News | Joele Frank Works LXP’s $5B Deal O'Dwyer's PR · 119d ago
- Brookfield, CPPIB Agree to Buy LXP Industrial for $5.2 Billion Bloomberg.com · 119d ago
- Brookfield, CPP Investments to buy LXP Trust for $5.2B cash (LXP:NYSE) Seeking Alpha · 119d ago
- Brookfield and CPP Investments to Buy LXP Industrial for $5.2 Billion WSJ · 119d ago
Topics
Related trends
Argenx to acquire Unnatural Products in deal worth up to $1.15B
Argenx agrees to acquire Unnatural Products for up to $1.15 billion, betting on AI-guided macrocycle technology to expand oral peptide drug development.
Exclusive
Broadridge Financial Solutions integrates Dinari dShares tokenized U.S. equities and ETFs into its proxy voting infrastructure.
Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Kimberly-Clark has finalized a $40 billion acquisition of Tylenol maker Kenvue, restructuring the global consumer health and wellness landscape.
Salesforce agrees to buy Cresta (CRM:NYSE)
Salesforce has entered into a definitive agreement to acquire the startup Cresta for $2.7 billion, marking its third acquisition in just two weeks.
Marvell Could Be Making a $115 Billion Mistake With Lumentum Purchase
Marvell Technology's massive $115 billion all-stock acquisition of Lumentum sparks intense debate over AI networking valuations and strategic risk.
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
India's Affle moves to acquire Israeli ad-tech firm Perion Network in a cash deal valued at $420 million.